Structures by: Ebby N.
Total: 18
C13H11NO2
C13H11NO2
Acta Crystallographica Section C (1995) 51, 8 1595-1602
a=10.021(3)Å b=5.991(2)Å c=18.094(6)Å
α=90° β=101.10(3)° γ=90°
C14H13NO2
C14H13NO2
Acta Crystallographica Section C (1995) 51, 8 1595-1602
a=11.28(5)Å b=7.92(3)Å c=13.45(5)Å
α=90° β=105.16(8)° γ=90°
C13H10ClNO2
C13H10ClNO2
Acta Crystallographica Section C (1995) 51, 8 1595-1602
a=7.236(7)Å b=7.714(3)Å c=21.663(7)Å
α=90° β=112.34(6)° γ=90°
C10H11NO2
C10H11NO2
Acta Crystallographica Section C (1995) 51, 8 1595-1602
a=9.80(2)Å b=15.88(5)Å c=9.38(2)Å
α=96.08(8)° β=105.80(8)° γ=77.30(10)°
C16H10O4
C16H10O4
Acta Crystallographica Section C (1999) 55, 9 1591-1593
a=10.1700(10)Å b=12.8970(10)Å c=9.8010(10)Å
α=90.000° β=105.3580(10)° γ=90.000°
Methyl (1<i>H</i>-benzimidazol-2-ylsulfanyl)acetate
C10H10N2O2S
Acta Crystallographica Section E (2007) 63, 10 o3987-o3987
a=9.337(9)Å b=13.418(15)Å c=9.667(8)Å
α=90° β=116.04(7)° γ=90°
3-(1H-Benzimidazol-2-ylsulfanyl)propan-1-ol
C10H12N2O1S1
Acta Crystallographica Section E (2007) 63, 11 o4463-o4463
a=7.1472(3)Å b=11.5574(6)Å c=12.5284(6)Å
α=90° β=98.343(4)° γ=90°
2-Methylsulfanyl-1-(morpholin-4-ylmethyl)-1H-benzimidazole
C13H17N3O1S1
Acta Crystallographica Section E (2007) 63, 11 o4218-o4218
a=6.2461(2)Å b=9.7949(2)Å c=11.6966(5)Å
α=75.4750(10)° β=84.8080(10)° γ=76.251(2)°
3-(3-Chlorophenyl)-1-(2-methylimidazo[1,2-a]pyridin-3-yl)prop-2-en-1-one
C17H13Cl1N2O1
Acta Crystallographica Section E (2007) 63, 12 o4758-o4759
a=4.784(2)Å b=21.690(2)Å c=13.773(9)Å
α=90° β=93.425(4)° γ=90°
5-Nitro-2-(piperidin-1-yl)benzaldehyde
C12H14N2O3
Acta Crystallographica Section E (2009) 65, 11 o2880
a=5.686(2)Å b=10.102(5)Å c=10.221(4)Å
α=80.767(2)° β=80.733(3)° γ=86.034(2)°
C10H13NO2
C10H13NO2
Acta Crystallographica Section C (1995) 51, 8 1595-1602
a=10.749(9)Å b=9.509(3)Å c=17.977(5)Å
α=90° β=146.08(7)° γ=90°
C16H9NO6
C16H9NO6
Zeitschrift für Kristallographie - New Crystal Structures (1999) 214, 4 481-482
a=5.553(1)Å b=7.692(1)Å c=15.676(1)Å
α=90.00(1)° β=92.812(1)° γ=90.00(1)°
C16H9FO4
C16H9FO4
Zeitschrift für Kristallographie - New Crystal Structures (1999) 214, 4 483-484
a=15.173(1)Å b=6.069(1)Å c=14.344(1)Å
α=90.00(1)° β=110.074(1)° γ=90.00(1)°
C15H12Cl2O2
C15H12Cl2O2
Zeitschrift für Kristallographie - New Crystal Structures (1999) 214, 4 485-486
a=7.534(1)Å b=16.230(1)Å c=11.911(1)Å
α=90.000(1)° β=108.382(1)° γ=90.000(1)°
C11H11NO4
C11H11NO4
Zeitschrift für Kristallographie - New Crystal Structures (1999) 214, 4 479-480
a=8.861(1)Å b=11.794(1)Å c=10.891(1)Å
α=90.000(1)° β=103.682(1)° γ=90.000(1)°
3-(4-Fluorophenyl)-1-(2-methylimidazo[1,2-<i>a</i>]pyridin-3-yl) prop-2-en-1-one
C17H13F1N2O1
Zeitschrift für Kristallographie - New Crystal Structures (2009) 224, 1 81
a=6.7597(2)Å b=28.4154(8)Å c=7.3112(2)Å
α=90° β=106.4720(10)° γ=90°
C12H20ClNO4
C12H20ClNO4
Zeitschrift für Kristallographie - New Crystal Structures (2002) 217, 2 289-291
a=14.8626(5)Å b=11.7049(8)Å c=16.2790(10)Å
α=90.0000(1)° β=90.329(4)° γ=90.0000(1)°
C12H8Cl2O2S
C12H8Cl2O2S
Zeitschrift für Kristallographie - New Crystal Structures (2001) 216, 3 393-394
a=8.0220(10)Å b=7.9820(10)Å c=10.8420(10)Å
α=79.7140(10)° β=72.9860(10)° γ=67.2650(10)°